We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this article, we are going to take a look at where Doximity, Inc. (NYSE:DOCS) stands against the other health information services stocks.
Health Information Services stocks have become a key focus for investors as AI starts to enter more domains in 2025. Some of the most amazing gains have come in health information services stocks that are utilizing AI to improve research and services in the healthcare sector.
The healthcare information services sector allows investors to gain exposure to a number of growing and emerging technologies including cloud-backed software solutions to physician enablement platforms. Some of the companies in our list are surging based on earnings anticipation while others are increasing in share price because of their upcoming products or revenue growth.
To come up with our list of top 10 health information services stocks outpacing the broader market in 2025, we only considered stocks with a market cap of at least $2 billion that were outperforming the S&P 500 index.
A pathologist and a laboratory assistant in a laboratory researching medical news and data.
Doximity, Inc. (NYSE:DOCS)
Doximity, Inc. (NYSE:DOCS) is a digital platform for medical practitioners in the US that provides a network where healthcare professionals can connect to stay up-to-date about the latest news and research. The company mainly offers its services to pharmaceutical manufacturers, physician assistants, medical students, physicians, healthcare systems, and nurse practitioners.
The stock is up over 45% this year as a result of strong Q3 performance as shares surged about 21% right after the company reported its Q3 strong earnings last week.
Doximity, Inc. (NYSE:DOCS) also received an upgrade from Leerink Partners with an Outperform rating and a raised price target from $60 to $90. This upgrade came as the company reported solid revenue growth in Q3 exceeding expectations and giving strong guidance for the ongoing quarter. The firm recorded 25% YoY revenue growth with a stable 93% gross margin.
Based on strong financial results, management was able to raise Q4 guidance and now it expects a 13% revenue growth at midpoint, while operating margins are predicted to grow by 6%. The company is improving efficiencies with cost reduction and continuous revenue expansion as it outpaces the broader market in 2025.
According to analyst Michael Cherny:
we see the continuation of core growth trends, driven by better attach rates on early customer buys and the long-term portal expansion as driving an ongoing positive reversion cycle. This should drive consistent upside to EBITDA…
Overall DOCS ranks 3rd on our list of the health information services stocks outpacing the market in 2025. While we acknowledge the potential of DOCS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as DOCS but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
Disclosure: None. This article was originally published at Insider Monkey.